Abstract
In early 2016, the international group of expert members of the European League Against Rheumatism (EULAR), the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), and the European Vasculitis Society (EUVAS) published new guidelines for the diagnosis and management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (SV). These guidelines are an important step in the development of the concept of ANCA-SV and have resulted from the systematic generalization of current scientific achievements and clinical experience. Fifteen recommendations proposed by the EULAR/ERA-EDTA highlight a wide range of problems of ANCA-SV and should contribute to the improvement of the diagnosis, efficiency of therapy and prognosis of these diseases. The aim of the publication is to provide the general characteristics of the main provisions of the guidelines.
Highlights
В начале 2016 г. международной группой экспертов – членов Европейской антиревматической лиги (EULAR), Европейской ассоциации по изучению болезней почек (ERA-EDTA) и Европейского общества изучения васкулитов (EUVAS) были опубликованы новые рекомендации по диагностике и лечению системных васкулитов (СВ), ассоциированных с антинейтрофильными цитоплазматическими антителами (АНЦА)
In early 2016, the international group of expert members of the European League Against Rheumatism (EULAR), the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), and the European Vasculitis Society (EUVAS) published new guidelines for the diagnosis and management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (SV). These guidelines are an important step in the development of the concept of ANCA-SV and have resulted from the systematic generalization of current scientific achievements and clinical experience
Fifteen recommendations proposed by the EULAR/ERA-EDTA highlight a wide range of problems of ANCA-SV and should contribute to the improvement of the diagnosis, efficiency of therapy and prognosis of these diseases
Summary
В начале 2016 г. международной группой экспертов – членов Европейской антиревматической лиги (EULAR), Европейской ассоциации по изучению болезней почек (ERA-EDTA) и Европейского общества изучения васкулитов (EUVAS) были опубликованы новые рекомендации по диагностике и лечению системных васкулитов (СВ), ассоциированных с антинейтрофильными цитоплазматическими антителами (АНЦА). Международной группой экспертов – членов Европейской антиревматической лиги (European League Against Rheumatism, EULAR), Европейской ассоциации по изучению болезней почек (European Renal Association – European Dialysis and Transplant Association, ERA-EDTA) и Европейского общества изучения васкулитов (European Vasculitis Society, EUVAS) проводилась масштабная работа, в итоге которой были согласованы и в начале 2016 г. Ведение больных АНЦА-СВ следует осуществлять при участии экспертных центров (уровень доказательности 3 / сила рекомендации С).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
